體外診斷試劑和細胞培養基市場規模、佔有率和成長分析：按產品類型、應用和地區分類－2026-2033年產業預測

2024年全球體外診斷和細胞培養基市場價值為828億美元，預計將從2025年的862.8億美元成長到2033年的1199.1億美元。預測期（2026-2033年）的複合年成長率預計為4.2%。

體外診斷和細胞培養基市場的主要驅動力是日益成長的對準確、快速生物學數據的需求，這些數據對於指導臨床決策和促進生物製藥開發至關重要。該市場涵蓋多種產品，例如指南、儀器和試劑，這些產品支持研發和生產過程中疾病生物標記的檢測和細胞增殖。高診斷準確性可降低治療的不確定性，而高品質的培養基則有助於生產可靠的生物製藥。檢測需求的成長和單株抗體生產的擴張都印證了這一點。精準醫療、細胞療法和生物製藥生產的融合正在為整個診斷和培養基供應鏈拓展機會。為了滿足日益成長的單株抗體和疫苗生產需求，定製配方和一次性培養基形式的創新正在推動生產流程的最佳化和污染風險的降低。

全球體外診斷與細胞培養基市場促進因素

全球體外診斷和細胞培養基市場的發展主要受生物製藥公司研發管線擴張和開發活動的推動。這些公司在藥物發現、篩檢和生物製藥生產等各個環節都需要可靠的檢測方法和高品質的培養基，從而導致對先進解決方案的需求不斷成長。因此，供應商正積極尋求配方創新並擴大生產規模，以提高產品的可用性和多樣性。這種與研發需求的協同效應正在促進整個價值鏈的合作，並透過持續的採購和技術進步進一步加速市場成長。

全球體外診斷和細胞培養基市場的限制因素

由於法規結構複雜且不斷演變，體外診斷試劑和細胞培養基的全球市場面臨嚴峻挑戰。這些法規帶來了沉重的合規負擔，可能阻礙產品上市並增加研發成本。製造商必須遵守各種區域標準，並證明產品的安全性、性能和質量，這減緩了創新速度，並阻礙了中小企業進入市場。此外，這些監管要求要求大量的文件和檢驗，使國際商業化更加複雜，減緩了新技術在實驗室中的應用速度，儘管科學技術不斷進步，但仍阻礙了整體市場成長。

體外診斷和細胞培養基的全球市場趨勢

在全球體外診斷和細胞培養基市場，一個顯著的趨勢是人工智慧技術的整合，這些技術能夠加速診斷並簡化實驗室工作流程。這些創新工具利用機器學習演算法進行檢測設計和影像分析，從而加快診斷開發迭代速度並提高可重複性。複雜生物訊號與臨床背景的整合正在加速預測性生物標記和自適應檢測策略的出現，並提升其臨床意義。此外，分析流程的自動化增強了資料管理和檢驗過程，促進了診斷試劑生產商、實驗室和醫療服務提供者之間的協作，同時支援適用於分散式醫療的各種檢測方法。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

市場考察

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場吸引力指數
• PESTEL 分析
• 監理情勢
• 案例研究

全球體外診斷試劑和細胞培養基市場規模：按產品類型和複合年成長率分類（2026-2033 年）

• 體外診斷（IVD）
  • 感染疾病
  • 腫瘤學
  • 心血管疾病
  • 代謝性疾病
  • 免疫疾病
  • 其他
• 細胞培養基
  • 生物製藥生產
  • 藥物發現與開發
  • 診斷
  • 再生醫學
  • 其他

全球體外診斷試劑和細胞培養基市場規模：按應用和複合年成長率分類（2026-2033 年）

• 體外診斷（IVD）
  • 感染疾病
  • 腫瘤學
  • 循環系統疾病
  • 代謝性疾病
  • 免疫疾病
  • 其他
• 細胞培養基
  • 生物製藥生產
  • 藥物發現與開發
  • 診斷
  • 再生醫學
  • 其他
• 最終用戶
  • 醫院/診斷檢查室
  • 製藥和生物技術公司
  • 研究機構和學術機構
  • 其他

全球體外診斷試劑及細胞培養基市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 2023-2025年營收年比比較

主要企業簡介

• Thermo Fisher Scientific
• Abbott Laboratories
• Roche Diagnostics
• BD（Becton, Dickinson and Company）
• Qiagen
• Agilent Technologies
• PerkinElmer
• Bio-Rad Laboratories
• Merck Group
• Siemens Healthineers
• Illumina
• Genomatix
• Promega Corporation
• Cell Signaling Technology
• Lonza Group
• Sigma-Aldrich
• Eppendorf
• Hologic
• 10X Genomics
• Sartorius AG

結論與建議

Global In Vitro Diagnostics And Cell Culture Medias Market size was valued at USD 82.8 Billion in 2024 and is poised to grow from USD 86.28 Billion in 2025 to USD 119.91 Billion by 2033, growing at a CAGR of 4.2% during the forecast period (2026-2033).

The in vitro diagnostics and cell culture media market is primarily driven by the rising need for precise and rapid biological data, essential for guiding clinical decisions and enhancing biopharmaceutical development. This market includes a variety of products such as assays, instruments, and reagents that support disease biomarker detection and cell growth for research and manufacturing. Diagnostic accuracy reduces treatment uncertainties, while high-quality media facilitates dependable biologics production, evident from increased testing demands and monoclonal antibody manufacturing. The convergence of precision medicine, cell therapy, and biologics manufacturing broadens opportunities across diagnostics and media supply chains. Innovations in custom formulations and single-use media formats are emerging to meet the growing demands of monoclonal antibody and vaccine production, optimizing manufacturing processes and mitigating contamination risks.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global In Vitro Diagnostics And Cell Culture Medias market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global In Vitro Diagnostics And Cell Culture Medias Market Segments Analysis

Global in vitro diagnostics and cell culture medias market is segmented by product type, application and region. Based on product type, the market is segmented into In Vitro Diagnostics (IVD) and Cell Culture Media. Based on application, the market is segmented into In Vitro Diagnostics (IVD), Cell Culture Media and End User. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global In Vitro Diagnostics And Cell Culture Medias Market

The global market for in vitro diagnostics and cell culture media is driven by the increasing expansion of research pipelines and development activities undertaken by biopharmaceutical companies. These firms require reliable assays and high-quality media for various processes such as discovery, screening, and biologics production, leading to a heightened demand for advanced solutions. As a result, suppliers are motivated to innovate formulations and scale up manufacturing, thereby improving product availability and diversity. This synergy between research and development needs fosters collaborative efforts throughout the value chain, further propelling market growth through ongoing procurement and technological advancements.

Restraints in the Global In Vitro Diagnostics And Cell Culture Medias Market

The global market for in vitro diagnostics and cell culture media faces notable challenges due to complex and evolving regulatory frameworks. These regulations impose significant compliance burdens that can hinder product introductions and inflate development costs. Manufacturers are required to navigate a variety of regional standards and demonstrate safety, performance, and quality, which can decelerate innovation and deter smaller companies from market participation. Additionally, these regulatory demands complicate international commercialization by necessitating extensive documentation and validation, ultimately slowing the pace at which new technologies become available in laboratories and hampering overall market growth, despite ongoing scientific advancements.

Market Trends of the Global In Vitro Diagnostics And Cell Culture Medias Market

The global in vitro diagnostics and cell culture media market is witnessing a significant trend towards the integration of AI-enabled technologies, which enhance diagnostic acceleration and streamline laboratory workflows. These innovative tools leverage machine learning algorithms for assay design and image interpretation, facilitating rapid iteration and increased reproducibility in diagnostic development. The synthesis of complex biological signals with clinical context is driving the emergence of predictive biomarkers and adaptive testing strategies, thereby amplifying clinical relevance. Additionally, automation in analytical pipelines is enhancing data curation and validation processes, fostering collaboration among diagnostics manufacturers, laboratories, and healthcare providers while enabling a wider range of assays suitable for decentralized care.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Case Studies

Global In Vitro Diagnostics and Cell Culture Medias Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• In Vitro Diagnostics (IVD)
  • Infectious Diseases
  • Oncology
  • Cardiovascular Diseases
  • Metabolic Disorders
  • Immunological Disorders
  • Others
• Cell Culture Media
  • Biopharmaceutical Production
  • Drug Discovery & Development
  • Diagnostics
  • Regenerative Medicine
  • Others

Global In Vitro Diagnostics and Cell Culture Medias Market Size by Application & CAGR (2026-2033)

• Market Overview
• In Vitro Diagnostics (IVD)
  • Infectious Diseases
  • Oncology
  • Cardiovascular Diseases
  • Metabolic Disorders
  • Immunological Disorders
  • Others
• Cell Culture Media
  • Biopharmaceutical Production
  • Drug Discovery & Development
  • Diagnostics
  • Regenerative Medicine
  • Others
• End User
  • Hospitals & Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Research & Academic Institutes
  • Others

Global In Vitro Diagnostics and Cell Culture Medias Market Size & CAGR (2026-2033)

• North America (Product Type, Application)
  • US
  • Canada
• Europe (Product Type, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genomatix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sigma-Aldrich
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eppendorf
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10X Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations